• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SENSOR; IMPLANTABLE GLUCOSE MONITORING SYSTEM SENSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SENSOR; IMPLANTABLE GLUCOSE MONITORING SYSTEM SENSOR Back to Search Results
Model Number 101368-67A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erythema (1840); Hematoma (1884); Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Pain (1994); Discomfort (2330)
Event Date 05/24/2023
Event Type  Injury  
Manufacturer Narrative
This report is being submitted retrospectively as part of internal review.The risks identified for the eversense¿ cgm system are common to all cgm systems even though a minor surgical procedure is required for insertion and removal of the sensor.These include local infection, pain or discomfort, inflammation, bleeding at the insertion or removal site, bruising, itching, scarring or skin discoloration, hematoma, erythema, adhesive tape irritation and sensor fracture.There is no remedial action/corrective action/preventive action/field safety corrective action required in this case as the device is not defective.The sterilization record for this lot of sensor was reviewed and the sensor was sterilized as per specifications.
 
Event Description
Senseonics was recently made aware of an incident where one of the patients who was inserted with an eversense sensor reported the incision site started to turn red and there was slight pain when touched a week after the insertion and stated the incision is now healed.The patient reported that his physician did not prescribe any cream or antibiotics.The eversense sensor was not removed.The patient could not be reached after multiple attempts to determine if he developed an infection at the insertion site.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SENSOR
Type of Device
IMPLANTABLE GLUCOSE MONITORING SYSTEM SENSOR
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18455962
MDR Text Key332206994
Report Number3009862700-2023-00382
Device Sequence Number1
Product Code QCD
Combination Product (y/n)Y
Reporter Country CodeIT
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 01/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date07/18/2019
Device Model Number101368-67A
Device Catalogue NumberFG-4400-XX-302
Device Lot NumberWP04608
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/04/2019
Initial Date FDA Received01/05/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured08/28/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-